<DOC>
	<DOCNO>NCT00985270</DOCNO>
	<brief_summary>This clinical trial design study effect rifampicin glucose , lipid hormone homeostasis healthy volunteer . The main hypothesis rifampicin lower fast glucose enhances insulin sensitivity . The study randomize , placebo-controlled , open-label cross-over trial . Twelve subject give 600 mg rifampicin day week compare one-week placebo arm . There least 4-week wash-out arm . The main outcome measure change fast glucose HOMA-IR-index ( calculate base fast glucose insulin ) .</brief_summary>
	<brief_title>Pregnane X Receptor ( PXR ) Agonist Rifampicin Effects Glucose , Lipid Hormone Homeostasis</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy volunteer Age 1840 year Any continuous medication Any significant disease Allergy rifampicin Pregnancy breast feed Fear needle previous difficult blood sampling Substance abuse Participation another clinical drug trial within 1 month enrollment Use soft contact lens</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>